Class Action

Advil, Tylenol, DayQuil, NyQuil, TheraFlu, Sudafed, and Other Cold and Flu Medicines

Class Action

Advil, Tylenol, DayQuil, NyQuil, TheraFlu, Sudafed, and Other Cold and Flu Medicines


Case Name (Date)

Chamberlain et al. v. Johnson & Johnson Consumer Inc., RB Health LLC, GlaxoSmithKline Consumer Healthcare Holdings (US), LLC
23-cv-4435, E.D. Penn.
(Nov. 2023)

Travis et al. v. Procter & Gamble Co., Kenvue, Inc., McNeil Consumer Healthcare, Reckitt & Benckiser LLC and GlaxoSmithKline, LLC
23-cv-607, S.D. Ohio
(Sept. 2023)


Product/Service

Advil, Tylenol, DayQuil, NyQuil, TheraFlu, Sudafed, and other cold and flu medicines


Allegations

Falsely marketing that medicines are decongestants when the active ingredient (phenylephrine) is not an effective decongestant


Status

Pending



Class-Action Tracker


The Latest

Filters

Gillette Engaged in Deceptive Made in USA Marketing

Press Release

Gillette Engaged in Deceptive Made in USA Marketing

Ad Watchdog TINA.org Files FTC Complaint MADISON, CONN. January 23, 2018 – Despite a national advertising campaign showcasing patriotic imagery, highlighting its Boston headquarters, and heavily promoting its “Made in…


Show More